Orthofix’s impressive line of products is continued with their third generation allograft, the Trinity ELITE. Processed by the Musculoskeletal Transplant Foundation, a nonprofit organization dedicated to providing quality types of tissue, this fully moldable implant with viable cells provides a unique alternative to autografting.
With over 150,000 Trinity Evolution® procedures to date, the Trinity ELITE adds to the already honorable portfolio. This product focuses on the three physiological components of robust bone formation: osteoconductive scaffold (interconnected scaffold meant for bone ingrowth), verified osteoinductive potential (which is demineralized cortical bone), and a reliable number of cells contained within the bone matrix. Osteogenic cells include adult mesenchymal stem cells and osteoprogenitor cells.
Every step taken in the creation of the Trinity ELITE is done so with the intent of maximizing the health and vitality of mesenchymal cells, also called MSCs, and osteoprogenitor cells, or OPCs. Studies show that MSCs have short lifespans, and decline with age. As these cells age, their abilities to regenerate may decline as well. In Trinity ELITE, the health of these cells starts with the quality.
Before these products are created, Orthofix demands a number of requirements. These include strict donor screening processes, time-sensitive processing, controlled rate of freezing for optimal cell vitality, cryopreservation in liquid nitrogen at -185℃, and a passing of the Musculoskeletal Transplant Foundation’s stringent release criteria. The expiration date of Trinity ELITE products must reflect real time testing.
For those in need of surgical repair or improvements of any bone, the Trinity ELITE is the best option available. Because of its fully moldable design, its viable cells, and a minimum of 500,000 cells per cubic centimeter, Orthofix’s revolutionary product provides a potentially much more beneficial alternative to autografting. For more on this and other products, visit Orthofix.com.